AT

Axsome Therapeutics

AXSM
NASDAQHealth Care

Recent Patents

axsm
1 year ago

Filed a patent for "compositions for delivery of reboxetine" on Thu, February 27, 2025

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for treating adults with adhd" on Fri, June 16, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for the treatment of adhd" on Wed, September 13, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for the treatment of adhd" on Mon, October 9, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for the treatment of certain neurological conditions" on Thu, December 7, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for the treatment of certain neurological conditions" on Thu, December 7, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "solriamfetol for improving cognitive health in apnea patients" on Thu, December 21, 2023

New US Patent
axsm
over 1 year ago

Filed a patent for "methods of modulating tetrabenazine metabolites plasma levels using bupropion" on Thu, October 31, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "pharmaceutical compositions comprising bupropion and cysteine" on Thu, August 22, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "dosage forms and methods for enantiomerically enriched or pure bupropion" on Thu, August 22, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "dosage forms and methods for enantiomerically enriched or pure bupropion" on Thu, September 5, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, August 8, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, July 25, 2024

New US Patent
axsm
over 1 year ago

Filed a patent for "methods of modulating tetrabenazine metabolites plasma levels using bupropion" on Thu, July 18, 2024

New US Patent
axsm
almost 2 years ago

Filed a patent for "microparticles containing bupropion" on Mon, August 8, 2022

New US Patent
axsm
almost 2 years ago

Filed a patent for "compounds and combinations thereof for treating neurological and psychiatric conditions" on Wed, September 21, 2022

New US Patent
axsm
almost 2 years ago

Filed a patent for "use of mazindol to treat nervous system disorders" on Wed, October 5, 2022

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, March 30, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, April 6, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, April 27, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, June 8, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "microparticles containing bupropion" on Thu, January 4, 2024

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, July 13, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "pharmaceutical compositions comprising meloxicam" on Thu, July 27, 2023

New US Patent
axsm
almost 2 years ago

Filed a patent for "dosage forms and methods for enantiomerically enriched or pure bupropion" on Thu, August 10, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...